Questions for 5 April Investor Call, page-110

20 million in 3 years was not that crazy....

1) If the GSK toothbrush went ahead as they seemed to think it would in 2014

AND

2) If the Coty deal for dermaportation went ahead as they seemed to think it would in 2014

AND

3) If P&G had not sold off 43 of its beauty brands in 2015, thus killing off some of the promising areas where OBJ was involved, AND perhaps putting a pause on SK-II/Olay progress during the restructuring.



______________

If we are going to be backward focussed (and there is a place for it), I would still love to have an explanation of how payment for delivery of 4o copies of a "prototype" device for "consumer efficacy testing" qualifies as royalties and allowed ths board to award themselves 15 million shares? Does the board have ANY CLUE how transparent and selfish this share grab was? Do they realise how this (among other causes) has destroyed the trust of shareholders (Trust being one of the few things that sustained shareholders over many years)? And looking to the future... (as asked by others) . What is the board doing now to restore trust.